Mogy Joel R Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$185K Hold
975
0.01% 103
2026
Q1
$165K Hold
975
0.01% 98
2025
Q4
$165K Hold
975
0.01% 99
2025
Q3
$141K Hold
975
0.01% 101
2025
Q2
$123K Hold
975
0.01% 102
2025
Q1
$125K Hold
975
0.01% 98
2024
Q4
$129K Hold
975
0.01% 100
2024
Q3
$142K Hold
975
0.01% 102
2024
Q2
$134K Hold
975
0.01% 99
2024
Q1
$134K Hold
975
0.01% 104
2023
Q4
$132K Hold
975
0.01% 101
2023
Q3
$119K Hold
975
0.01% 102
2023
Q2
$124K Hold
975
0.01% 112
2023
Q1
$126K Buy
+975
New +$128K 0.01% 114

Other funds holding IBB

Mogy Joel R Investment Counsel's IBB Position: Q2 2026 in Review

Mogy Joel R Investment Counsel held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 975 shares worth $185K. The position accounts for 0.01% of the portfolio, ranked #103.

Mogy Joel R Investment Counsel first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. 395 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Mogy Joel R Investment Counsel held 975 shares of iShares Biotechnology ETF worth $185K as of Q2 2026.
  • Mogy Joel R Investment Counsel left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of Mogy Joel R Investment Counsel's portfolio in Q2 2026, its #103 holding.
  • Mogy Joel R Investment Counsel first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
  • 395 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Mogy Joel R Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.